A Hospital Based Cross-sectional Study on Demographic Distribution of Both Symptomatic and Asymptomatic Patients an Art at Westren Region of Rajasthan.
DOI:
https://doi.org/10.48165/zx0d5r14Keywords:
Haart, Haart Hiv, Morbidity, MortalityAbstract
Background: Over the past two decades with the advent of highly active antiretroviral therapy (HAART), there is a substantial increase in the life span of HIV patients. Morbidity and mortality due to human immunodeficiency virus (HIV) continue to be major problems in developing countries like India. Subjects and Methods: The present study was a cross sectional hospital based study for a period of twelve months from 1st Nov. 2015 to 31st Oct. 2016 at ART center P.B.M. Hospital, Bikaner. 100 HIV+ patients on ART were included in the study by consecutive sampling technique. Results: We found that Maximum number of study participants in age group of 31-40 years in both study (50%) and control (42%) group. Males were higher in study (76%) as well as control (64%) group than females .Among the subjects mostly belonged to lower socioeconomic status followed by Medium and High socioeconomic status. Most of the subjects in study (92%) as well as control (94%) groups were married. Conclusion: We conclude that Males were higher in study (76%) as well as control (64%) group than females .Among the subjects mostly belonged to lower socioeconomic status followed by Medium and High socioeconomic status.
References
1. Joint United Nations Program on HIV/AIDS. 14 January 2007 accession date. AIDS epidemic update: December 2005. http://www.unaids.org/epi/2005.
2. WHO. 14 January 2007 accession date. Progress on global access to HIV antiretroviral therapy: an update on “3 by 5.” http://www.who.int/3by5/june2005execsummary.pdf.
3. Arinola, O. G., K. S. Adedapo, A. O. Kehinde, J. A. Olaniyi, and M. O. Akiibinu. 2004. Acute phase proteins, trace elements in asymptomatic human immunodeficiency virus infection in Nigerians. Afr. J. Med. Med. Sci. 33:317-322.
4. Feldman, J. G., D. N. Burns, S. J. Gange, P. Bacchetti, M. Cohen, K. Anastos, M. Nowicki, R. Delapena, and P. Miotti. 2000. Serum albumin as a predictor of survival in HIV-infected women in the Women's Interagency HIV Study. AIDS14:863-870.
5. Feldman, J. G., P. Goldwasser, S. Holman, J. DeHovitz, and H. Minkoff. 2003. C-reactive protein is an independent predictor of mortality in women with HIV-1 infection. J. Acquir. Immune Defic. Syndr. 32:210-214.
6. India HIV Estimations 2015 Technical Report. National AIDS Control Organization & National Institute of Medical Statistics, ICMR. MoHFW, Government of India.
7. Vishwanath A, Quaiser S, Khan R. Role of high-sensitivity C-reactive protein measurements in HIV patients. Indian J Sex Transm Dis [serial online] 2016 [cited 2016 Dec 30];37:123-8. Available from: http://www.ijstd.org/text.asp?2016/37/2/123/192127
8. Ugwu MC. Human serum protein and C-Reactive Protein levels among HIV infected subjects in uromi and its environs in Edo, Nigeria. IJBAIR, 2016, 5(3): 74-80.
